. . . . . . . "[Recent advances include the identification of PNPLA3 as a modifier of disease outcome across the full spectrum of NAFLD from steatosis to advanced fibrosis and hepatocellular carcinoma; and the discovery of TM6SF2 as a potential 'master regulator' of metabolic syndrome outcome, determining not only risk of advanced liver disease, but also cardiovascular disease outcomes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:18:55+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .